Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1980 Apr;35:43–54. doi: 10.1289/ehp.803543

Role of polyclonal cell activation in the initiation of immune complex-mediated pulmonary injury following antigen inhalation.

B J Shenker, T N Mann, W F Willoughby
PMCID: PMC1568463  PMID: 6250813

Abstract

The lung, by virtue of its anatomic situation, provides environmental antigens with unique access to host lymphoid tissues. In order to better understand the biologic consequences of antigen inhalation, we developed in animal model in which soluble proteins are administered in aerosol form to rabbits. By labeling these proteins with fluorochrome dyes or radioactive isotopes, the uptake, distribution, and fate of such proteins can be demonstrated both morphologically and quantitatively. Prompt host-antibody responses can be demonstrated to inhaled antigen, but not to comparable amounts of ingested antigen. Repeated administrations of antigen aerosol to immune animals produced little injury; in contrast, administration of aerosols containing phytohemagglutinin or cancanavalin A (Con A), plant lectins which activate leucocytes in a polyclonal fashion, induced a diffuse interstitial pneumonitis. When immune animals inhaled antigen plus Con A, devastating pulmonary necrosis was induced, in association with localized deposits of immune complexes containing antigen, antibody and complement. Such necrotic injury healed by scarring within 4 weeks. The necrotizing injury could be prevented by either decomplementation with cobra venom factor, or through inhibition of leucocyte responsiveness to Con A by administration of cholera toxin, a cAMP agonist. These studies indicate that antigen inhalation may serve as an important means of establishing "natural" immunity to environmental agents, but also may lead to severe pulmonary injury and fibrosis where the agents inhaled act not only as antigens but as polyclonal leucocyte activators as well.

Full text

PDF
43

Images in this article

47FIGURE 2. (a)
on p.47
47FIGURE 2. (b)
on p.47
49FIGURE 3. (a)
on p.49
49FIGURE 3. (b)
on p.49
50FIGURE 4. (a)
on p.50
50FIGURE 4. (b)
on p.50

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agrawal B. B., Goldstein I. J. Protein-carbohydrate interaction. VI. Isolation of concanavalin A by specific adsorption on cross-linked dextran gels. Biochim Biophys Acta. 1967 Oct 23;147(2):262–271. [PubMed] [Google Scholar]
  2. Daniele R. P., Altose M. D., Rowlands D. T., Jr Immunocompetent cells from the lower respiratory tract of normal human lungs. J Clin Invest. 1975 Oct;56(4):986–995. doi: 10.1172/JCI108179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Edelson P. J., Cohn Z. A. Effects of concanavalin A on mouse peritoneal macrophages. I. Stimulation of endocytic activity and inhibition of phago-lysosome formation. J Exp Med. 1974 Nov 1;140(5):1364–1386. doi: 10.1084/jem.140.5.1364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Möller G., Andersson J., Pohlit H., Sjöberg O. Quantitation of the number of mitogen molecules activating DNA synthesis in T and B lymphocytes. Clin Exp Immunol. 1973 Jan;13(1):89–99. [PMC free article] [PubMed] [Google Scholar]
  5. Schatz M., Patterson R., Sommers H. M., Harris K. E. Mitogen-induced lymphocyte and cutaneous reactions in dogs. Int Arch Allergy Appl Immunol. 1977;54(2):121–128. doi: 10.1159/000231815. [DOI] [PubMed] [Google Scholar]
  6. Shenker B. J., Gray I. Cyclic nucleotide metabolism during lymphocyte transformation. I. Enzymatic mechanisms in changes in cAMP and cGMP concentration in Balb/c mice. Cell Immunol. 1979 Mar 1;43(1):11–22. doi: 10.1016/0008-8749(79)90145-x. [DOI] [PubMed] [Google Scholar]
  7. Sobel A. T., Branellec A. I., Blanc C. J., Lagrue G. A. Physicochemical characterization of a vascular permeability factor produced by con A-stimulated human lymphocytes. J Immunol. 1977 Oct;119(4):1230–1234. [PubMed] [Google Scholar]
  8. Stadecker M. J., Leskowitz S. The cutaneous basophil response to mitogens. J Immunol. 1974 Aug;113(2):496–500. [PubMed] [Google Scholar]
  9. Vischer T. L., LoSpalluto J. J. The differential effect of cholera toxin on the lymphocyte stimulation induced by various mitogens. Immunology. 1975 Aug;29(2):275–282. [PMC free article] [PubMed] [Google Scholar]
  10. Warren K. S., Mahmoud A. A., Boros D. L., Rall T. W., Mandel M. A., Carpenter C. C., Jr In vivo suppression by cholera toxin of cell-mediated and foreign body inflammatory responses. J Immunol. 1974 Mar;112(3):996–1007. [PubMed] [Google Scholar]
  11. Willoughby J. B., Willoughby W. F. In vivo responses to inhaled proteins. I. Quantitative analysis of antigen uptake, fate, and immunogenicity in a rabbit model system. J Immunol. 1977 Dec;119(6):2137–2146. [PubMed] [Google Scholar]
  12. Willoughby W. F., Barbaras J. E., Wheelis R. Immunologic mechanisms in experimental interstitial pneumonitis. Chest. 1976 Feb;69(2 Suppl):290–294. doi: 10.1378/chest.69.2_supplement.290. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES